» Articles » PMID: 14573334

Association Between Microalbuminuria and the Metabolic Syndrome: NHANES III

Overview
Journal Am J Hypertens
Date 2003 Oct 24
PMID 14573334
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated whether microalbuminuria was associated with the metabolic syndrome by comparing the strength of the association between microalbuminuria and the syndrome as a whole and its individual components. This investigation included 5659 women and men aged 20 to 80 years from the cross-sectional, nationally representative, Third National Health and Nutrition Examination Survey (NHANES III: 1988-1994). Metabolic syndrome was defined as any three of the following: increased waist circumference, increased triglycerides, decreased HDL cholesterol, increased blood pressure, or high fasting glucose. Microalbuminuria was defined as urinary albumin/creatinine ratio of 30 to 300 mg/g. Microalbuminuria was present in 7.8% of women and 5.0% of men. Log linear analysis revealed a significant association between the metabolic syndrome and microalbuminuria in both genders (women chi(2) = 44.1; men chi(2) = 59.6; P <.0001 for both). Microalbuminuria was more common in both women (odds ratio [OR] = 2.2; 95% confidence interval [CI] 1.44, 3.34) and men (OR = 4.1; 95% CI 2.45, 6.74) with metabolic syndrome compared to those without it; 34% of women and 42% of men with microalbuminuria also had metabolic syndrome. After adjusting for other components of the metabolic syndrome, hypertension demonstrated the strongest association with microalbuminuria in both women (OR = 3.34; 95% CI 2.45, 4.55) and men (OR = 2.51; 95% CI 1.63, 3.86). Microalbuminuria and metabolic syndrome are associated in a large, nationally representative cohort, possibly due to early renal effects of hypertension, and it may be useful to consider microalbuminuria as a component of the metabolic syndrome.

Citing Articles

The relation between proteinuria and the severity of COVID-19.

Fukui A, Takeshita K, Nakashima A, Maruyama Y, Tsuboi N, Hoshina T Clin Exp Nephrol. 2023; 28(3):235-244.

PMID: 37962747 PMC: 10881620. DOI: 10.1007/s10157-023-02428-9.


Comparison of Microalbuminuria Status in Type 2 Diabetes Mellitus Patients With Chronic Periodontitis: A Cross-Sectional Study.

Nair D, Shanthi B, Baby P Cureus. 2022; 14(7):e27383.

PMID: 36046275 PMC: 9419016. DOI: 10.7759/cureus.27383.


Diagnostic accuracy of a urine dipstick for detecting albuminuria in hypertensive patients.

Panta P, Techakehakij W F1000Res. 2022; 9:1244.

PMID: 36017252 PMC: 9366238. DOI: 10.12688/f1000research.25564.3.


Spot urinary microalbumin concentration, metabolic syndrome and type 2 diabetes: Tehran lipid and glucose study.

Gaeini Z, Bahadoran Z, Mirmiran P, Norouzirad R, Ghasemi A, Azizi F BMC Endocr Disord. 2022; 22(1):59.

PMID: 35260113 PMC: 8905801. DOI: 10.1186/s12902-022-00976-x.


Parental overnutrition by carbohydrates in developmental origins of metabolic syndrome.

Seda O Physiol Res. 2022; 70(Suppl4):S585-S596.

PMID: 35199545 PMC: 9054190. DOI: 10.33549/physiolres.934806.